56211-40-6
56211-40-6
Chemical Structure
Torsemide
Synonym(s): Torasemide
- CAS No.: 56211-40-6
- Formula:C16H20N4O3S
- Molecular Weight:348.42
IUPAC Name: N-(isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide
InChIKey: NGBFQHCMQULJNZ-UHFFFAOYSA-N
SMILES: O=S(C1=C(NC2=CC=CC(C)=C2)C=CN=C1)(NC(NC(C)C)=O)=O
Biological Activity: Torsemide (Torasemide) is an orally active loop diuretic. Torsemide has anti-aldosterone and vasodilatory effects. Torsemide also can be used for the research of heart failure, renal disease and hepatic cirrhosis[1][1][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Torsemide | 99.35% | Torsemide (Torasemide) is an orally active loop diuretic. Torsemide has anti-aldosterone and vasodilatory effects. Torsemide also can be used for the research of heart failure, renal disease and hepatic cirrhosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Torsemide (Standard) | 99.89% | Torsemide (Standard) is the analytical standard of Torsemide. This product is intended for research and analytical applications. Torsemide (Torasemide) is an orally active loop diuretic. Torsemide has anti-aldosterone and vasodilatory effects. Torsemide also can be used for the research of heart failure, renal disease and hepatic cirrhosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Torsemide-d7 | Torsemide-d7 is the deuterium labeled Torsemide. Torsemide (Torasemide) is an orally active loop diuretic. Torsemide has anti-aldosterone and vasodilatory effects. Torsemide also can be used for the research of heart failure, renal disease and hepatic cirrhosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Ishido, H., et al. Torasemide for the Treatment of Heart Failure. Cardiovascular & Hematological Disorders-Drug Targets. 2008. 8(2), 127–132. [Content Brief]
- [3]. H A Friedel, et al. Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs. 1991 Jan;41(1):81-103. [Content Brief]
